Federation Des Caisses Desjardins Du Quebec Ionis Pharmaceuticals Inc Transaction History

Federation Des Caisses Desjardins Du Quebec

$17.5 Billion
Q2 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Aug 30, 2024	SELL	$25.61 - $35.1 $5,122 - $7,020	-200 Closed	0 $0
Q3 2021 Aug 30, 2024	BUY	$33.54 - $40.55 $6,708 - $8,109	200 New	200 $6.71 Million
Q4 2020 Aug 30, 2024	BUY	$45.3 - $60.27 $57,576 - $76,603	1,271 New	1,271 $71.9 Million
Q1 2020 Aug 30, 2024	SELL	$41.6 - $63.4 $779,168 - $1.19 Million	-18,730 Closed	0 $0
Q4 2019 Aug 30, 2024	BUY	$53.85 - $65.27 $1.01 Million - $1.22 Million	18,730 New	18,730 $1.13 Billion
Q1 2018 Aug 30, 2024	SELL	$44.08 - $55.05 $1,278 - $1,596	-29 Closed	0 $0
Q3 2017 Aug 30, 2024	SELL	$45.56 - $59.57 $4,556 - $5,957	-100 Reduced 77.52%	29 $1.47 Million
Q2 2017 Aug 30, 2024	BUY	N/A	129	129 $6.56 Million

Others Institutions Holding IONS

# of Institutions

389

Shares Held

125M

Call Options Held

2.25M

Put Options Held

510K

Vanguard Group Inc Valley Forge, PA

13.8M
Shares

$550 Million
0.01% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

12.6M
Shares

$502 Million
0.38% of portfolio
Black Rock Inc. New York, NY

10.3M
Shares

$410 Million
0.01% of portfolio
Bellevue Group Ag Kuesnacht, V8

8.26M
Shares

$328 Million
6.59% of portfolio
Wellington Management Group LLP Boston, MA

6.57M
Shares

$261 Million
0.06% of portfolio

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.64B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.

Account